TF
IDXX icon

Tompkins Financial’s Idexx Laboratories IDXX Stock Holding History

Tompkins Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$4.06K – 619
2025
Q4 		$4.06K Buy
+6
New +$4.09K ﹤0.01% 501
2021
Q4 		– Sell
-140
Closed -$87K – 367
2021
Q3 		$87K Buy
+140
New +$94.1K 0.02% 188
2021
Q1 		$128K Hold
261
– – 0.02% 162
2020
Q4 		$130K Buy
261
+140
+116% +$62.6K 0.02% 152
2020
Q3 		$48K Hold
121
– – 0.01% 239
2020
Q2 		$40K Sell
121
-35
-22% -$10.1K 0.01% 253
2020
Q1 		$38K Buy
+156
New +$40.7K 0.01% 247
2016
Q1 		– Sell
-52
Closed -$4K – 521
2015
Q4 		$4K Buy
+52
New +$3.71K ﹤0.01% 473

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tompkins Financial's IDXX Position: Q1 2026 in Review

Tompkins Financial sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 6 shares — an estimated $4.06K sold.

Tompkins Financial first reported a position in IDXX in Q4 2015 and held it in 8 quarters. The position peaked at $130K in Q4 2020. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Tompkins Financial reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Tompkins Financial sold 6 Idexx Laboratories shares in Q1 2026, an estimated $4.06K.
  • Tompkins Financial first reported a position in Idexx Laboratories in Q4 2015 and held it in 8 quarters.
  • Tompkins Financial's Idexx Laboratories position peaked at $130K in Q4 2020.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Tompkins Financial's 13F filing for Q1 2026, filed 9 Apr 2026.